Investing Profile

Shinichiro Fuse

Advisor
Partner/Managing Director at TPG Life Sciences Innovation
Cambridge, Massachusetts
Photo of Shinichiro Fuse, Advisor
cb
Advisor
MPM BioImpact Managing Director
6
CompanyStageDateRound SizeTotal Raised
Sudo Biosciences
Series BFeb 2024$30M
Series BDec 2023$120M
$180M
Co-investors: Daniel Estes (Frazier Healthcare Partners), Christopher Gagliardi (Sanofi Ventures)
Santa Ana Bio
Series AFeb 2023$43M
$170M
Co-investors: Brendan Bulik-Sullivan (GV (Google Ventures)), Vineeta Agarwala (Andreessen Horowitz), Christine Borowski (Access Biotechnology), Jerel Davis (Versant Ventures), Peter Emtage (Versant Ventures)
Orna Therapeutics
Series AFeb 2021$80M
SeedJan 2020$20M
$320M
Co-investors: Sakae Asanuma (Taiho Ventures), Ansbert Gadicke (MPM Capital)
Triplet Therapeutics
Series ADec 2019$49M
$49M
Co-investors: Jean-François Formela (Atlas Venture)
Managing Director MPM BioImpact2018 - 2021